Moderna, Inc. (MRNA) Form 8-K — Sep 30, 2026
Moderna announced on September 30, 2026 the appointment of Juan Andres as its first Chief Operating Officer, effective October 5, 2026, reporting to CEO Stephane Bancel and serving on the Executive Committee. Andres, a returning Moderna veteran who led the company's COVID-19 vaccine manufacturing scale-up before retiring in 2023, will receive an $800,000 base salary, a 90% bonus target, and a $5 million new hire equity award vesting over four years. The COO role was created as Moderna prepares for the potential launch and scale-up of intismeran autogene, its individually personalized cancer vaccine jointly developed with Merck, following positive Phase 3 results.
Key figures
- Effective date
- October 5, 2026
- Annual base salary
- 800000
- Equity vesting period
- four years
- Annual bonus target pct
- 90%
- Annual equity target range
- $4,000,000 to $5,000,000
- New hire equity award value
- 5000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.